CONCORD, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated diseases, today announced intent to submit to the…
Category: Business
EyeCare Partners Announces Sale of Optometry Business
ST. LOUIS–(BUSINESS WIRE)–EyeCare Partners LLC (“EyeCare Partners” or the “Company”), the nation’s leading provider of clinically integrated eye care, announced today that it has entered into an agreement for the sale of its optometry business to MyE…
MyEyeDr. To Acquire EyeCare Partners Optometry Division
VIENNA, Va.–(BUSINESS WIRE)–MyEyeDr., a leading provider of comprehensive eye care and eyewear solutions, announced today that it has entered into an agreement with EyeCare Partners to acquire its optometry division, consisting of over 300 offices, i…
Verbraucherumfrage von STAAR Surgical: 71 Prozent der Deutschen möchten auf Sehhilfen verzichten, kennen aber ihre Alternativen nicht
HAMBURG, Germany–(BUSINESS WIRE)–Die STAAR Surgical Company, weltweit führender Anbieter von phakischen Intraokularlinsen mit der EVO™-Produktfamilie implantierbarer Collamer®-Linsen (EVO ICL™) zur Sehkorrektur, hat die Ergebnisse ihrer globalen Verb…
STAAR Surgical Board Approves $50 Million Share Repurchase Authorization
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO™ family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced that its Board of Directors, at a regul…
STAAR Surgical Board Approves $50 Million Share Repurchase Authorization
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO™ family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced that its Board of Directors, at a regul…
Ora Launches Clinical Intelligence Committee, Bringing Collective KOL Guidance to Ophthalmic Research
BOSTON–(BUSINESS WIRE)– #clinicalresearch–Ophthalmic CRO Ora launches Clinical Intelligence Committee, expert network helps innovators navigate complexity, bring therapies to patients faster
Merck’s Remigromig, a Tri-specific Agonist of the Wingless-related Integration Site (Wnt) Pathway, Met Primary Endpoint in the Pivotal Phase 2b/3 BRUNELLO Study of Adults with Diabetic Macular Edema
RAHWAY, N.J.–(BUSINESS WIRE)–Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced topline results from the pivotal Phase 2b/3 BRUNELLO trial in adults with diabetic macular edema (DME). BRUNELLO is the first of two…
Onnuri Smile Eye Clinic’s Patented 1mm SMILE Pro Technology Highlights Safety and Rapid Recovery
SEOUL, South Korea–(BUSINESS WIRE)– #CataractSurgery–Onnuri Smile Eye Clinic, a South Korean ophthalmology clinic, announced its patented 1mm SMILE Pro technique for safer surgery and faster recovery.
Science Corporation Names Darius Shahida as President
ALAMEDA, Calif.–(BUSINESS WIRE)–Science Corporation, the neural engineering and brain-computer interface company, today announced the appointment of its Chief Strategy Officer, Darius Shahida, as President, effective immediately. Shahida will continu…
Sling Therapeutics Announces First Patients Dosed in Global Phase 3 ORBIT Pivotal Trial of Linsitinib for Thyroid Eye Disease
ANN ARBOR, Mich.–(BUSINESS WIRE)–Sling Therapeutics, Inc., a clinical-stage biopharmaceutical company developing the first and only late-stage oral small-molecule therapy for thyroid eye disease (TED), today announced the first patients have been dos…
Sling Therapeutics Announces $123 Million Series C Financing to Advance Phase 3 Development of its Oral Small Molecule IGF-1R Inhibitor for Thyroid Eye Disease
ANN ARBOR, Mich.–(BUSINESS WIRE)–Sling Therapeutics, Inc., a clinical-stage biopharmaceutical company developing the first and only late-stage oral small-molecule therapy for thyroid eye disease (TED), today announced the close of a $123 million Seri…
Simon Eye Expands Pennsylvania Footprint Through Partnership With Ganly Vision Care
KENNETT SQUARE, Pa.–(BUSINESS WIRE)–Simon Eye Associates (“Simon Eye”), a growing regional provider of comprehensive and advanced eye care, has partnered with Ganly Vision Care in Kennett Square, Pennsylvania, effective September 14, 2026. The partne…
Eyexora to Host Two-Part Key Opinion Leader Webinar Series
NEW YORK & SINGAPORE–(BUSINESS WIRE)–Eyexora, a biotech company pioneering innovative therapies for ophthalmic diseases through a hub-and-spoke model, today announced that it will host a key opinion leader (KOL) webinar series featuring globally reco…
Stuart Therapeutics, Inc. to Present at the Citizens Private Ophthalmology Summit
STUART, Fla.–(BUSINESS WIRE)–Stuart Therapeutics, Inc. (“Stuart”), a late-stage biopharmaceutical company developing a new class of therapeutics designed to repair helical collagen for the treatment of eye diseases, today announced that Eric Schlumpf…
STAAR Surgical Releases Landmark Global Report Showing Structural Multi-Market Shift Toward Lens-Based Vision Correction
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO™ family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today released a new report entitled The Future of Refr…
Ashvattha Therapeutics Announces Investor and Conference Presentations
REDWOOD CITY, Calif.–(BUSINESS WIRE)–Ashvattha Therapeutics (“Ashvattha”), a clinical-stage company developing an at-home subcutaneous (subQ) monthly treatment, announced presentations at HC Wainwright Conference, Ophthalmology Futures Retina Forum, …
Tenpoint Therapeutics to Participate in Upcoming Investor Conferences and Medical Meetings
LONDON & WARREN, N.J.–(BUSINESS WIRE)–Tenpoint Therapeutics, Ltd., a global commercial ophthalmic pharmaceutical company focused on developing groundbreaking treatments to improve vision in the aging eye, today announced participation in upcoming inv…
Warby Parker Announces Participation in the Goldman Sachs 33rd Annual Global Retailing Conference
NEW YORK–(BUSINESS WIRE)–Warby Parker Inc. (NYSE: WRBY) (the “Company”), a direct-to-consumer lifestyle brand focused on vision for all, today announced that the Company will be presenting at the Goldman Sachs 33rd Annual Global Retailing Conference …
STAAR Surgical Names Former CEO David Bailey as Chief Commercial Officer
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced the appointme…